The surveillance of Neisseria gonorrhoeae antimicrobial susceptibility in the European Union/European Economic Area (EU/EEA) is essential for detecting emerging and increasing antimicrobial resistance. Since 2009, this surveillance has been co-ordinated by the European Centre for Disease Prevention and Control (ECDC). The quality-assured data produced can be used to inform treatment guidelines.
For 2019, 24 EU/EEA countries reported 1 049 confirmed cases of leptospirosis, the highest number in the period from 2015–2019, possibly because of environmental conditions favourable to hosts, and/or increase of activities at risk for infection.